Genus plc (LON:GNS) declared a dividend on Thursday, September 5th, Upcoming.Co.Uk reports. Stockholders of record on Thursday, November 7th will be given a dividend of GBX 18.80 ($0.25) per share on Friday, November 29th. This represents a dividend yield of 0.68%. The ex-dividend date is Thursday, November 7th. This is a boost from Genus’s previous dividend of $8.90. The official announcement can be seen at this link.
The company has a quick ratio of 1.32, a current ratio of 2.08 and a debt-to-equity ratio of 22.58. The business has a 50 day simple moving average of GBX 2,604.92 and a 200-day simple moving average of GBX 2,495.63. The company has a market capitalization of $1.76 billion and a price-to-earnings ratio of -253.70. Genus has a 12 month low of GBX 2,090 ($27.31) and a 12 month high of GBX 2,950 ($38.55).
A number of equities analysts have recently commented on GNS shares. Liberum Capital reiterated a “buy” rating on shares of Genus in a research note on Friday, May 17th. Peel Hunt reiterated a “buy” rating and issued a GBX 3,200 ($41.81) price objective on shares of Genus in a research note on Thursday, August 22nd. Stifel Nicolaus started coverage on Genus in a research note on Wednesday, May 29th. They issued a “hold” rating and a GBX 2,685 ($35.08) price objective on the stock. Finally, Peel Hunt reissued a “buy” rating on shares of Genus in a research report on Monday. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company. Genus currently has an average rating of “Buy” and a consensus price target of GBX 2,819.17 ($36.84).
Genus plc operates as an animal genetics company in North America, Latin America, rest of Europe, the Middle East, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand.
Recommended Story: Death Cross
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.